Mavenir Extends AI and Analytics Portfolio to Enable Mobile Network Optimization, Automation & Security
11.3.2021 17:00:00 EET | Business Wire | Press release
Mavenir, the industry’s only end-to-end cloud-native Network Software Provider and a leader in accelerating software network transformation for communications service providers (CSPs), announced today its extended Artificial Intelligence (AI) and Analytics portfolio to enable closed-loop automation and drive digital transformation.
AI and machine learning (ML) in mobile network infrastructure is expected to lower costs by automating functions that typically require human interaction and to speed new revenue generating service offerings, becoming increasingly important as edge, open radio access networks (Open RAN), and 5G cores get deployed.
Mavenir’s AI and Analytics portfolio includes solutions designed to analyze and derive inferences from vast amounts of unstructured data to automate networks, achieve cost savings, and build out 5G use cases. Many Industry 4.0 use cases such as Intelligent Video Analytics and AR/VR are enabled by 5G that require AI-driven inferences at the edge. Mavenir’s portfolio includes these AI-enabled applications for Network Automation, Intelligent Operations, EdgeAI, and Network Security.
|
1)
|
Network Automation: Mavenir’s RAN Intelligent Controller (RIC) and Network Data Analytics Function (NWDAF) follow the specifications introduced by the O-RAN Alliance and 3GPP and operate as the heart of a network automation vision. The RIC and NWDAF enable the network to dynamically adapt to traffic conditions using machine learning (ML)-based algorithms and applications that can be deployed in any network in a multi-vendor environment. Mavenir’s containerized RIC and NWDAF product capabilities include: |
|
|
|
|
2)
|
Intelligent Operations: By automating network operational processes with AI and analytics solutions, operators should be able to substantially reduce the cost and time from traditional, more labor-intensive methods such as drive testing, log inspection, troubleshooting, and manual calibration. With AI-based prediction engines, operators can achieve intelligent capacity planning and reduce the possibility of large-scale network outages. With anomaly detection capability, operators can uncover underlying network faults that are not easily visible. This AI-driven Operations (AIOps) solution using ML techniques plays a key role in reducing operating expenses and gives operators complete control over their networks. |
|
|
|
|
3)
|
5G EdgeAI: Mavenir’s 5G EdgeAI solution includes Intelligent Video Analytics that can support myriad of use cases from facial recognition to anomaly detection for smart city and industry 4.0 use cases. Next generation of AR/VR applications are accelerated and enhanced by this edge platform. Large number of sensor data gets analyzed and actions are taken in a matter of milliseconds by the edge Industrial Internet of Things (IIoT) analytics application. |
|
|
|
|
|
“AI is the key driver for Industry 4.0, providing real-time insights & control of industrial processes. Low latency, high density of 5G are also enablers, so in essence, the combination of 5G and AI = Industry 4.0,” said Kuntal Chowdhury, SVP and GM, Mavenir AI and Analytics Business Unit. “While Mavenir’s AI and Analytics solutions are now available as standalone solutions, we have been offering intelligent insights as integrated solutions to Tier 1 customers around the world for years. Currently over 200 systems are deployed in more than 80 customer networks and our solutions process and analyze billions of records per day, offering real-time/near-real-time insights to optimize network performance with little to no human intervention.” |
|
|
|
|
4)
|
Network security: As new vulnerabilities arise, Mavenir’s Fraud Management and Security Suite protect the network in real-time with predictive analytics and ML. The Real-Time Fraud Management and Security analytics is leveraging unique ML algorithms and a specifically designed framework suited to manage the volume, velocity, and variety of structured and unstructured data over wireless networks. |
|
|
|
|
|
“Mavenir Security and Anti-Fraud Solutions based on AI/ML are taking care of on-going revenue savings at Telefónica Argentina,” says Diego Quevedo, Core Network Solution Design Lead, Telefónica Argentina. “We are in close cooperation with Mavenir to ensure the up-to-date protection of our network.” |
|
|
|
|
|
“Mavenir’s approach of applying Real-Time Machine Learning technology to protect key operator services and revenue has been highly valued by customers,” said Ilia Abramov, VP and GM, Mavenir Security BU. “New threats raised in the recent years and increasing attack vectors on Mobile Network Services have been successfully detected and blocked though our installed base. The increased level of trust of our AI/ML technology has been confirmed with substantial growth in additional network implementations in the last year.” |
“Leveraging our deep AI/ML knowledge and advanced capabilities enables Communications Service Providers to optimize, automate and advance their mobile networks for the future of 5G,” said BG Kumar, President, Mavenir’s Communications Services Business Group. “Network automation and service protection driven by AI/ML are core capabilities of Mavenir and one of the highest priorities of our customers, and we are proud to provide this solution set to enable them to realize their vision.”
Mavenir’s AI/ML and Analytics solutions and Fraud/Security solutions are deployed at multiple Tier 1 operator networks across North America, EMEA, and APAC regions. Additionally, Mavenir is dedicated to continuous AI/ML innovation through the R&D Center of Excellence in Brno, Czech Republic, and R&D in Richardson TX and Bangalore, India.
About Mavenir:
Mavenir is the industry's only end-to-end, cloud-native Network Software and Solutions/Systems Integration Provider, focused on accelerating software network transformation. Mavenir offers a comprehensive end-to-end product portfolio across every layer of the network infrastructure stack for communications service providers and enterprises. From 5G application layers (VoLTE, Messaging) to Packet Core and RAN, Security, Edge Analytics and AI, Mavenir leads the way in evolved, cloud-native networking solutions enabling innovative and secure experiences for end users.
Leveraging innovations in Mobile Core with IMS (VoLTE, VoWiFi, Advanced Messaging/RCS), and Packet Core (vEPC, 5G Core) as well as Radio Access/Edge (OpenRAN), Private Networks, as well as Mobile Services and Applications such as Digital Enablement. Mavenir accelerates digital network transformation for more than 250+ CSP customers in over 120 countries, which serve over 50% of the world’s subscribers. www.mavenir.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210311005034/en/
Contact information
Maryvonne Tubb
Mavenir
PR@mavenir.com
Loren Guertin
MatterNow
mavenir@matternow.com
Kevin Taylor
GlobalResultsPR
mavenir@globalresultspr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
